Expand Healthcare support KDx Acceleration with the cMyC Cardiac Biomarker launch
Expand Healthcare support KDx with the launch of the novel cMyC (Cardiac Myosin-binding Protein C) cardiac biomarker. cMyC is a distinctive cardiac necrosis marker for triaging chest pain patients. It outperforms existing hs-Troponin assays for early Rule-out of Myocardial Infarction. More information about cMyC can be found at www.cmycbiomarker.com